MedPath
HSA Approval

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

SIN10991P

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

June 26, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01DB01

doxorubicin

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

DOXORUBICIN HCl EQV DOXORUBICIN

50 mg/vial

Doxorubicin
© Copyright 2025. All Rights Reserved by MedPath